Newton biotech gets $200M for rare muscle disease drug
Abcuro Inc. has raised a $200 million Series C financing to fund late-stage development and support commercial launch ...
News Medical on MSN21h
Inhaled antibody therapy shows promise for COVID-19 treatment
The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.